Skip to main content

Weight Loss (Obesity / Overweight) News (Page 17)

Related terms: Weight Gain, Overweight, Weightloss, Anorexiants, Obesity, Obese, Weight Loss, Loose Weight, Lost Weight, diet drugs, diet medications, anti-obesity medications, Weight Loss Medications

Health Literacy-Informed Digital Intervention Reduces Obesity at Age 2 Years

FRIDAY, Nov. 8, 2024 – A health literacy-informed digital intervention reduces the incidence of obesity at 24 months of age, according to a study published online Nov. 3 in the Journal of the...

Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year

THURSDAY, Nov. 7, 2024 – Expanding access to obesity medications such as glucagon-like peptide 1 (GLP-1) receptor agonists and dual gastric inhibitory polypeptide and GLP-1 receptor agonists could...

PCOS Plus Obesity Can Be Hazardous in Pregnancy

WEDNESDAY, Nov. 6, 2024 – Women who are pregnant but who also have the ovarian cyst disorder polycystic ovary syndrome (PCOS) are at higher odds of giving birth to an underweight baby, new Norwegian...

U.S. Diabetes Rates Rise to Nearly 1 in 6 Adults

WEDNESDAY, Nov. 6, 2024 – Nearly 16% of American adults – that's close to 1 in 6 – now has diabetes, according to the latest data from the U.S. Centers for Disease Control and Prevention....

Improvement Seen in Some Features of PCOS With Weight Loss Interventions

MONDAY, Nov. 4, 2024 – Weight loss interventions are associated with improvement in some features of polycystic ovary syndrome (PCOS), according to a study published online Nov. 5 in the Annals of...

Medicaid Covers GLP-1 Meds for Obesity in Just 13 States

TUESDAY, Nov. 5, 2024 – Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently allow Medicaid to cover t...

Text-Messaging Program Helps Parents Keep Infants at Healthy Weight

MONDAY, Nov. 4, 2024 – Text messages and other online feedback can help prevent obesity in very young children, a new study demonstrates. Kids had a healthier weight-for-height growth curve during...

Weight-Loss Surgery for Teens Brings Lasting Benefit

FRIDAY, Nov. 1, 2024 – Hillary Fisher thinks receiving weight-loss surgery as a teenager put her on the path to a better life. Fisher is one of 260 teens who participated in a long-term study which...

ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal Cancer

FRIDAY, Nov. 1, 2024 – Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cancer (EO-CRC) in patients with diabetes regardless of...

Semaglutide Beneficial for People With Obesity, Knee Osteoarthritis

THURSDAY, Oct. 31, 2024 – For individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and pain related to knee osteoarthritis than placebo,...

Most Patients Can Keep Using GLP-1 Weight Loss Meds Before Surgeries

THURSDAY, Oct. 31, 2024 – A new guidance issued jointly by groups representing U.S. surgeons, anesthesiologists and gastroenterologists affirms that most people taking popular GLP-1 weight-loss meds...

Healthy Eating Index 2015 Score Linked to Overactive Bladder

TUESDAY, Oct. 29, 2024 – There is a positive association between a higher Healthy Eating Index (HEI)-2015 score and overactive bladder (OAB), according to a study published online Sept. 16 in...

What You Don't Know About Pancreatic Cancer Could Harm You

WEDNESDAY, Oct. 30, 2024 – Pancreatic cancer rates are rising in adults younger than 50, but many continue to believe it’s a disease that only affects the elderly, a new survey shows. Folks in that a...

Elevated BMI Linked to Postacute Sequelae of SARS-CoV-2 in Children

WEDNESDAY, Oct. 30, 2024 – For children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, elevated body mass index (BMI) is associated with an increased risk of postacute...

Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries

TUESDAY, Oct. 29, 2024 – Among privately insured patients, there was a doubling in the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as antiobesity treatment from 2022 to 2023, with a...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

bupropion, phentermine, Contrave, Ozempic, amphetamine, Saxenda, methamphetamine, Mounjaro, topiramate, view more... Wegovy, semaglutide, methylphenidate, Qsymia, Zepbound, liraglutide, tirzepatide, Adipex-P, Alli, orlistat, dulaglutide, garcinia cambogia, desvenlafaxine